Angus DC - Search Results

1

Calcium supplementation during sepsis exacerbates organ failure and mortality via calcium/calmodulin-dependent protein kinase kinase signaling.

Collage RD, Howell GM, Zhang X, Stripay JL, Lee JS, Angus DC, Rosengart MR. Collage RD, et al. Among authors: angus dc. Crit Care Med. 2013 Nov;41(11):e352-60. doi: 10.1097/CCM.0b013e31828cf436. Crit Care Med. 2013. PMID: 23887235 Free PMC article.

2

Short-term and long-term outcome prediction with the Acute Physiology and Chronic Health Evaluation II system after orthotopic liver transplantation.

Angus DC, Clermont G, Kramer DJ, Linde-Zwirble WT, Pinsky MR. Angus DC, et al. Crit Care Med. 2000 Jan;28(1):150-6. doi: 10.1097/00003246-200001000-00025. Crit Care Med. 2000. PMID: 10667515

3

Predicting hospital mortality for patients in the intensive care unit: a comparison of artificial neural networks with logistic regression models.

Clermont G, Angus DC, DiRusso SM, Griffin M, Linde-Zwirble WT. Clermont G, et al. Among authors: angus dc. Crit Care Med. 2001 Feb;29(2):291-6. doi: 10.1097/00003246-200102000-00012. Crit Care Med. 2001. PMID: 11246308

4

Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care.

Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Angus DC, et al. Crit Care Med. 2001 Jul;29(7):1303-10. doi: 10.1097/00003246-200107000-00002. Crit Care Med. 2001. PMID: 11445675

5

Epidemiology of sepsis: an update.

Angus DC, Wax RS. Angus DC, et al. Crit Care Med. 2001 Jul;29(7 Suppl):S109-16. doi: 10.1097/00003246-200107001-00035. Crit Care Med. 2001. PMID: 11445744 Review.

6

Cost-effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis.

Angus DC, Linde-Zwirble WT, Clermont G, Ball DE, Basson BR, Ely EW, Laterre PF, Vincent JL, Bernard G, van Hout B; PROWESS Investigators. Angus DC, et al. Crit Care Med. 2003 Jan;31(1):1-11. doi: 10.1097/00003246-200301000-00001. Crit Care Med. 2003. PMID: 12544986 Clinical Trial.

7

Drotrecogin alfa (activated) administration across clinically important subgroups of patients with severe sepsis.

Ely EW, Laterre PF, Angus DC, Helterbrand JD, Levy H, Dhainaut JF, Vincent JL, Macias WL, Bernard GR; PROWESS Investigators. Ely EW, et al. Among authors: angus dc. Crit Care Med. 2003 Jan;31(1):12-9. doi: 10.1097/00003246-200301000-00002. Crit Care Med. 2003. PMID: 12544987 Clinical Trial.

8

Effects of drotrecogin alfa (activated) on organ dysfunction in the PROWESS trial.

Vincent JL, Angus DC, Artigas A, Kalil A, Basson BR, Jamal HH, Johnson G 3rd, Bernard GR; Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) Study Group. Vincent JL, et al. Among authors: angus dc. Crit Care Med. 2003 Mar;31(3):834-40. doi: 10.1097/01.CCM.0000051515.56179.E1. Crit Care Med. 2003. PMID: 12626993 Clinical Trial.

9

Hospital costs in patients receiving prolonged mechanical ventilation: does age have an impact?

Chelluri L, Mendelsohn AB, Belle SH, Rotondi AJ, Angus DC, Donahoe MP, Sirio CA, Schulz R, Pinsky MR. Chelluri L, et al. Among authors: angus dc. Crit Care Med. 2003 Jun;31(6):1746-51. doi: 10.1097/01.CCM.0000063478.91096.7D. Crit Care Med. 2003. PMID: 12794415

10

Reassessing the value of short-term mortality in sepsis: comparing conventional approaches to modeling.

Clermont G, Angus DC, Kalassian KG, Linde-Zwirble WT, Ramakrishnan N, Linden PK, Pinsky MR. Clermont G, et al. Among authors: angus dc. Crit Care Med. 2003 Nov;31(11):2627-33. doi: 10.1097/01.CCM.0000094233.35059.81. Crit Care Med. 2003. PMID: 14605534

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

638 results

Search Page

Filters